AzTrials
AzTrials

Chest PainNCT02384863

The Evaluation and Management of Patients With Acute Chest Pain in China

An observational study of Chest Pain and Acute Coronary Syndrome, run by Yuguo Chen at 7 sites in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study is to describe the characteristics, evaluation, management and outcomes of acute chest pain, and to provide opportunities for future initiatives to improve the emergency care for patients experiencing acute chest pain in China. Read more about this study

Who is it for?
Any age
Conditions the study is for
Chest Pain, Acute Coronary Syndrome
How many people
18,000 participants
Where
7 sitesChina
Study dates
Oct 2014to Dec 2016
How long will I take part?
1 Year
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: consecutive patients attending the emergency department in 7 Chinese grade Ⅲ hospitals

Who may be able to join

  • Acute chest pain(pain in the area inferior to the clavicle, superior to the rib arch, and anterior to the bilateral posterior axillary line);
  • Possible Acute Coronary Syndrome;
  • Symptoms occurring within last 24 hours;
  • Informed consent from patient or next of kin.

Who cannot join

  • Arrhythmia or heart failure not cause by myocardial ischemia;
  • Confirmed lung disease without chest pain;
  • No onset of symptoms within last 24 hours;
  • No written consensus.

Trial locations and contacts

7 sites in 1 country.

Yuguo Chen, M.D., Ph.D. contact

86-18678812777

chen919085@126.com

7 sites in 1 country

China7 sites, 7 recruiting
  • West China Hospital

    Chengdu, Sichuan, 610041

    Yu Cao, M.D,Ph.D., 86-18980601184, yuyuer@126.com

    Yu Cao, M.D,Ph.D.

    Not yet recruiting
  • First Affiliated Hospital of Harbin Medical University

    Harbin, Heilongjiang, 150001

    Xiujie Wang, M.D,Ph.D, 86-13945690985, wangxiujie0709@sina.com

    Xiujie Wang, M.D,Ph.D

    Not yet recruiting
  • Qilu Hospital of Shandong University

    Jinan, Shandong, 250012

    Yuguo Chen, M.D., Ph.D., 86-18678812777, chen919085@126.com

    Yuguo Chen, M.D., Ph.D.

    Recruiting
  • Shanghai Chest Hospital

    Shanghai, Shanghai Municipality, 200030

    Weiyi Fang, M.D,Ph.D, 86-13916688508, fwychest@163.com

    Weiyi Fang, M.D,Ph.D

    Not yet recruiting
  • Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

    Shanghai, Shanghai Municipality, 200092

    Shuming Pan, M.D,Ph.D, 86-13801612110, drshumingpan@gmail.com

    Shuming Pan, M.D,Ph.D

    Not yet recruiting
  • Second Affiliated Hospital of Xi'an Jiaotong University

    Xi'an, Shaanxi, 710004

    Honghong Pei, M.D,Ph.D, 86-18991237562, 18991237562@163.com

    Honghong Pei, M.D,Ph.D

    Not yet recruiting
  • Henan Provincial Hospital

    Zhengzhou, Henan, 450003

    Yingjie Chu, M.D,Ph.D, 86-13937199780, hnqbdsl@126.com

    Yingjie Chu, M.D,Ph.D

    Not yet recruiting

Other trials in China

About this study

The purpose of this study is to describe the characteristics, evaluation, management and outcomes of acute chest pain, and to provide opportunities for future initiatives to improve the emergency care for patients experiencing acute chest pain in China.

Keywords
Chest Pain, Acute Coronary Syndrome, Cardiac, Emergency Department, Cardiac Testing, Healthcare Utilization, Patient Centered Outcomes, Shared Decision Making, Unnecessary hospital admissions, Decision Aid
Medical subject headings
Chest Pain, Acute Coronary Syndrome, Emergencies

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. in-hospital mortality

    Measured: During hospital stay,an expected average of 7 days

Secondary outcomes (3)
  1. Time between symptom onset and hospital admission

    Measured: Time interval from symptom onset to arrival at the Emergency Department,an expected median of 9 hours

  2. Major adverse cardiac events (MACE)

    Composite of major adverse cardiac events (MACE) including death, myocardial infarction and/or revascularization

    Measured: 1 year

  3. Cost-Effectiveness Analysis

    To study the cost-effectiveness ratios of diagnostic and management strategies for patients with acute chest pain

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Mar 2015 (estimated)
  2. Study startOct 2014
  3. Primary completionDec 2016 (estimated)
  4. Study completionDec 2016 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
18,000 participants (estimated)
Target duration
1 Year
IDs, dates and publications
ClinicalTrials.gov ID
NCT02384863
Sponsor's protocol ID
201502032
Other IDs
ChiCTR-IOQ-14005268
Status last verified
Mar 2015
First submitted
26 Feb 2015
Last updated
10 Mar 2015
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

An observational study of Chest Pain and Acute Coronary Syndrome, run by Yuguo Chen at 7 sites in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 10 Mar 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 7 sites in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Yuguo Chen, M.D., Ph.D. (86-18678812777, chen919085@126.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

in-hospital mortality (time frame: During hospital stay,an expected average of 7 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Mar 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in